The possible relationship between antecedent diabetic control, as determined by serial glycosylated haemoglobin (HbA1) measurements, and diabetic retinopathy was examined in 40 insulin-dependent and 41 non-insulin-dependent diabetics selected consecutively from our clinic population. Multiple logistic regression analysis demonstrated a significant association between mean HbAj and prevalence of retinopathy in both groups of patients. This association was independent of duration of diabetes which was also significantly associated with retinopathy prevalence. Hypertension and smoking were not obvious risk factors in this group of patients; an apparent association of hypertension and diabetes was entirely accounted for by a positive relationship between the presence of hypertension and duration of diabetes.
Introduction
Poor diabetic control is widely held to be a critical aetiological factor in diabetic retinopathy. However, evidence for the association remains equivocal. Studies in this area have attempted to relate prevalence of retinopathy either to mean blood glucose measurements at clinic visits"2 or single measurements of glycosylated haemoglobin2. While an inverse relationship between control and retinopathy has been demonstrated in insulin-dependent diabetics (IDD)'-, the data for non-insulin-dependent diabetics (NIDD) is contradictory" 2'6. The picture is further complicated by varying accounts of the influence of improvement in diabetic control on progression of retinopathy7 -9 and this has led to the suggestion that retinopathy, although initially related to the degree of glycaemia, is eventually an irreversible process'0. This possibility poses a major problem in the correlation of retinopathy and glycaemic control, because attempts to improve control may have been successfully undertaken after the microvascular pathology has become well established. This is particularly important in NIDD, which is often present in an asymptomatic form for a considerable length of time prior to diagnosis.
Measurements of blood glucose in the clinic setting should be a reliable indicator of diabetic control in NIDD patients, but their usefulness is limited by the fact that dietary compliance may be much better at the time of clinic visits than in the months between.
For these reasons the ideal method for correlating previous metabolic control with prevalence of dia-betic complications is one which provides something approaching an integral of blood sugar levels over as long a period as possible. Serial measurements of glycosylated haemoglobin go some of the way towards achieving this and have been available to our diabetic service for the past eight years. We now report the relationship between mean levels of glycosylated haemoglobin (HbA,) and prevalence of diabetic retinopathy in a randomly selected population of IDD and NIDD patients.
Patients and methods Forty IDD and 41 NIDD patients with diabetes of at least 3 years duration and normal renal function were selected consecutively at the time of routine annual clinical review and represented an unbiased cohort of our clinic population. The clinical review included measurement of blood pressure, assessment of peripheral vascular and nervous systems and smoking history. Fundoscopic examination was carried out through dilated pupils by the same ophthalmologist (WLA) throughout the study, and presence or absence and type of retinopathy was recorded.
Total glycosylated haemoglobin levels (HbA,) had previously been determined for each patient on a regular basis. The method employed was initially column chromatography"1 (until June 1983) and subsequently electroendosmosis'2. Results obtained by the former method (normal range 8.0-10.5%) were corrected to the latter range (normal range 5.5-8.4%) to facilitate statistical analysis. The mean of all available HbAl levels was calculated for each patient (a mean of 3 measurements per patient was used).
Multiple logistic regression analysis was used to assess the possible independent relationships between retinopathy (all types) and (a) mean HbA, level, (b) duration of diabetes, (c) presence of hypertension (diastolic BP>95 mmHg) and (d) smoking history.
Results
The mean data for NIDD and IDD patients are shown in Table 1 . Retinopathy was of background type in most patients, with < 40% showing progressive or proliferative change. For the purposes of analysis all grades of retinopathy were pooled. Retinopathy was associated with longer duration of diabetes in both groups of patients and also with apparently higher mean HbAj levels. However, Journal of the Royal Society of Medicine Volume 79 May 1986 275 HbA, level was associated with prevalence of retinopathy and no significant difference was evident between NIDD and IDD patients in this respect. Furthermore, no independent association was evident between duration of diabetes and mean HbA,.
There was no significant association between retinopathy and either hypertension or smoking. An apparent trend towards an association between retinopathy and hypertension was accounted for by a significant relationship between hypertension and duration of diabetes. The magnitude of the association between mean HbA, levels and prevalence of retinopathy was such that the apparent relative risk ofhaving retinopathy with a mean HbAl >9.5% was 4.0 (3.6 in NIDD, 5.2 in IDD; 95% confidence limits 1.4-11.0) having adjusted for duration.
Discussion
These findings demonstrate a statistically significant relationship between degree of glycaemia, as measured by serial HbA1 measurements, and retinopathy in both IDD and NIDD patients. and a single HbA, estimation at the time of ophthalmic assessment (9 years after diagnosis) in a large group of patients. Their findings tend to contradict the suggestion that established retinopathy may with time become independent ofdegree ofglycaemia. The duration of diabetes in the present study varied considerably so that the same arguments do not necessarily apply. However, many of the patients had been diagnosed several years prior to the advent of glycosylated haemoglobin measurements, and it is likely that the vast majority of NIDD patients had suffered from glucose intolerance for a considerable time prior to diagnosis. We would therefore suggest that poor glycaemic control constitutes a continuing risk factor for the development of retinopathy.
The failure of some studies to show such a relationship in NIDD patients could be due, at least in part, to reliance on mean clinic blood glucose measurements which may provide an unreliable and optimistic index of control if dietary compliance is variable. Our failure to demonstrate an association between hypertension and retinopathy independent of duration of diabetes emphasizes the importance of multiple logistic regression in the analysis of potential risk factors.
